E
Eric J. Topol
Researcher at Scripps Health
Publications - 1406
Citations - 162373
Eric J. Topol is an academic researcher from Scripps Health. The author has contributed to research in topics: Myocardial infarction & Angioplasty. The author has an hindex of 193, co-authored 1373 publications receiving 151025 citations. Previous affiliations of Eric J. Topol include Loyola University Chicago & Cleveland Clinic.
Papers
More filters
Journal ArticleDOI
The Myth of the Myocardial ‘Infarctlet’ During Percutaneous Coronary Revascularization Procedures
TL;DR: One of the most controversial issues in interventional cardiology today is whether small MIs, diagnosed by enzymatic abnormalities coincident with percutaneous coronary interventional procedures, are clinically relevant.
Journal ArticleDOI
Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience.
W. Brian Gibler,Paul W. Armstrong,E. Magnus Ohman,W. Douglas Weaver,Amanda Stebbins,Joel M. Gore,L. Kristin Newby,Robert M. Califf,Eric J. Topol +8 more
TL;DR: Certain groups of patients with AMI, including the elderly, women, diabetic patients, and minorities, exhibit delays to hospital arrival and treatment in the emergency setting, and patients and health care providers must be educated regarding high-risk populations for delay to maximize benefit from fibrinolytic therapy.
Journal ArticleDOI
Effects of Reteplase and Alteplase on Platelet Aggregation and Major Receptor Expression During the First 24 Hours of Acute Myocardial Infarction Treatment
Paul A. Gurbel,Victor L. Serebruany,Andrew R. Shustov,Raymond D. Bahr,Cynthia Carpo,E. Magnus Ohman,Eric J. Topol +6 more
TL;DR: In this article, the effects of reteplase and alteplases on platelet aggregation and major surface antigen expression during the first 24 hours of infarction therapy are unknown.
Journal ArticleDOI
Cost Effectiveness of Early Discharge after Uncomplicated Acute Myocardial Infarction
L. Kristin Newby,Eric L. Eisenstein,Robert M. Califf,Trevor D. Thompson,Charlotte L. Nelson,Eric D. Peterson,Paul W. Armstrong,Frans Van de Werf,Harvey D. White,Eric J. Topol,Daniel B. Mark +10 more
TL;DR: Hospitalization of patients with uncomplicated myocardial infarction beyond three days after thrombolysis is economically unattractive by conventional standards.
Journal ArticleDOI
Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial)
David J. Moliterno,Robert M. Califf,Frank V. Aguirre,Keaven M. Anderson,Kristina N. Sigmon,Harlan F. Weisman,Eric J. Topol +6 more
TL;DR: The activated clotting time (ACT) has been used during percutaneous transluminal coronary angioplasty to monitor the extent of thrombin inhibition and anti-coagulation from heparin in an attempt to minimize untoward thrombotic events and hemorrhagic complications.